This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The federal government said it "ran afoul of no statute" when it announced a 15%...
A judge in Singapore ordered the freezing of KBP Biosciences’ assets while Novo ...
Siegfried’s stock dipped by 6% on the Swiss stock exchange Tuesday after reporti...
Shortly after Robert F. Kennedy Jr. was confirmed as HHS secretary, the White Ho...
Solid Biosciences reported that three children with Duchenne muscular dystrophy ...
Arcus Biosciences presented new Phase 1/1b data for a kidney cancer program over...
Plus, news about Basilea, TME Pharma and Perceive Biotherapeutics: Septerna ...
A month after Biogen signaled plans to shift its attention to "external opportun...
Hikma Pharmaceuticals is asking the US Supreme Court to review a generic drug la...
The FDA has approved Bavarian Nordic’s chikungunya vaccine for adolescents and a...
Subsense, a startup building noninvasive technology to communicate with the brai...
AlgoTherapeutix’s topical non-opioid drug has flunked a mid-stage trial in chemo...
A biotech based in Vilnius, Lithuania has won the backing of Lux Capital as the ...
Atomwise spent most of its first 12 years talking up the potential of AI in maki...
The FDA approval of Romvimza in a rare cancer means Ono Pharmaceutical has a fig...
Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves crea...